SCM
GHDX

Stevens Capital Management’s Genomic Health, Inc. GHDX Stock Holding History

Stevens Capital Management’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-9,614
Closed -$281K – 1418
2013
Q4 		$281K Buy
+9,614
New +$305K 0.01% 802

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
ICM
IronBridge Capital Management Oakbrook Terrace, Illinois $1.65B AUM 18.98% 1-Year Est. Return

Stevens Capital Management's GHDX Position: Q1 2014 in Review

Stevens Capital Management sold out of Genomic Health, Inc. (GHDX) in Q1 2014, closing a stake of 9,614 shares — an estimated $281K sold.

Stevens Capital Management first reported a position in GHDX in Q4 2013 and held it in 1 quarter. The position peaked at $281K in Q4 2013. 101 funds tracked by Wall St. Rank hold GHDX as of Q1 2014.

  • Stevens Capital Management reported no remaining Genomic Health, Inc. position as of Q1 2014 after selling out during the quarter.
  • Stevens Capital Management sold 9,614 Genomic Health, Inc. shares in Q1 2014, an estimated $281K.
  • Stevens Capital Management first reported a position in Genomic Health, Inc. in Q4 2013 and held it in 1 quarter.
  • Stevens Capital Management's Genomic Health, Inc. position peaked at $281K in Q4 2013.
  • 101 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q1 2014.

Based on Stevens Capital Management's 13F filing for Q1 2014, filed 6 May 2014.